<div id="readability-page-1">09:10 AM EST, 12/24/2025 (MT Newswires) -- Teva Pharmaceutical Industries ( TEVA ) said Wednesday that S&amp;P Global Ratings (SPGI) has upgraded its long-term issuer credit rating to BB+ from BB.The company also said Moody's (MCO) affirmed its B1a rating and revised its outlook to positive from stable.Teva said the ratings decisions were based on its improvement in operating performance and its debt reduction policies, as well as momentum in its branded franchises and product launches.Shares of the pharmaceutical company were up 1% pre-bell. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

梯瓦制藥

梯瓦製藥的信用評級被標準普爾上調至 BB+，穆迪將其展望調整為積極，原因是運營表現改善、債務減少以及產品發佈勢頭強勁。股價在開盤前上漲了 1%

梯瓦製藥的信用評級被標普上調，穆迪上調其展望